Warner Bros. Discovery, Inc.
Pyridopyrimidine compounds acting as mTORC 1/2 dual inhibitors
Last updated:
Abstract:
Disclosed are a series of pyridopyrimidine compounds and a use of same in the preparation of drugs associated with mTORC 1/2 dual complex inhibitors, and specifically disclosed is a use of the compounds as shown in formula (IV), tautomers thereof or pharmaceutically acceptable salts thereof in the preparation of drugs associated with mTORC 1/2 dual complex inhibitors. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
2 Nov 2018
Issue date:
5 Jul 2022